TYMP promotes aggressive behavior of fibroblast-like synoviocyte in rheumatoid arthritis by upregulating autophagy through HIF-1α/ROS pathway
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by the enhanced proliferation, migration, and invasion of fibroblast-like synoviocyte (FLS). Thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor (PD-ECGF), plays important roles in cell proliferation and angiogenesis. Elevated levels of TYMP have been observed in RA, however, its functional role in RA FLS remains unclear. This study is aimed at clarifying the mechanism of action of TYMP in RA. The study examined the expression of TYMP in the synovial tissue of patients and collagen-induced arthritis (CIA) model mice. Gain- and loss-of-function experiments were performed in RA FLS to evaluate the effects of TYMP modulation on proliferation, migration, invasion, reactive oxygen species (ROS) production, and autophagy. The therapeutic effect of TYMP inhibition was further assessed in CIA mice. TYMP expression was significantly increased in RA synovial tissue and RA FLS compared with controls. Functional assays demonstrated that TYMP promoted proliferation, migration, and invasion of RA FLS. TYMP enhanced ROS production and upregulated autophagy-related proteins, including Beclin-1, p62, and LC3BII, via a HIF-1α-dependent pathway. Silencing TYMP suppressed ROS generation, autophagy activation, and the aggressive phenotype of RA FLS, whereas TYMP overexpression produced the opposite effects. Pharmacological inhibition of TYMP reduced synovial inflammation, hyperplasia, and expression of autophagy markers in CIA mice. Elevated TYMP expression contributes to the aggressive phenotype of RA FLS by upregulating HIF-1α/ROS-mediated autophagy. Targeting the the TYMP-HIF-1α axis to modulate ROS-associated autophagy-related signalling may represent a promising therapeutic strategy for RA.
Authors
- Shuoyang Zhang (ORCID: https://orcid.org/0009-0006-2964-9358)
- Ligang Jie (ORCID: https://orcid.org/0000-0001-5017-6272)
- Qing Tan
- Yinghua Zhu
- Ju Shao
- Hongyan Du
- Yuping Zhang
- Zikang Yin
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Zhujiang Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s10565-026-10329-2
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Guangdong Province
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China